文献速递心境障碍儿童青少年精神

激素避孕与自杀未遂及自杀的关联

Association of Hormonal Contraception With Suicide Attempts and Suicides.
PubMed 文献 · Am J Psychiatry · 2017-11-17

与从未使用者相比,当前或近期使用激素避孕者的自杀未遂相对风险为1.97(95%CI=1.85-2.10),自杀为3.08(95%CI=1.34-7.08),青少年女性相对风险最高。

要点

  • 当前或近期使用激素避孕者自杀未遂风险约为从未使用者的2倍(RR=1.97)。
  • 不同剂型风险不同,贴片最高(3.28),口服复方最低(1.91)。
  • 激素避孕与首次自杀未遂的关联在用药约2个月后达峰。

核心结论

  • 激素避孕使用与后续自杀未遂和自杀呈正相关,青少年女性相对风险最高。

研究设计与样本

  • 丹麦全国前瞻性队列研究,纳入15岁起无精神科诊断、无抗抑郁药及激素避孕使用史的妇女,随访1996—2013年。

主要发现

  • 识别6999例首次自杀未遂和71例自杀。
  • 当前或近期使用者自杀未遂相对风险1.97(95%CI=1.85-2.10),自杀相对风险3.08(95%CI=1.34-7.08)。
  • 口服复方产品自杀未遂风险1.91(95%CI=1.79-2.03),口服单孕激素产品2.29(95%CI=1.77-2.95),阴道环2.58(95%CI=2.06-3.22),贴片3.28(95%CI=2.08-5.16)。
  • 激素避孕与首次自杀未遂的关联在用药2个月后达峰。

关键数值与推荐

  • 自杀未遂相对风险:当前或近期使用者1.97(95%CI=1.85-2.10)。
  • 自杀相对风险:当前或近期使用者3.08(95%CI=1.34-7.08)。
  • 口服复方产品1.91(95%CI=1.79-2.03)、口服单孕激素产品2.29(95%CI=1.77-2.95)、阴道环2.58(95%CI=2.06-3.22)、贴片3.28(95%CI=2.08-5.16)。

临床怎么用

  • 对青少年女性处方激素避孕时应评估情绪与自杀风险并告知相关信号。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The purpose of this study was to assess the relative risk of suicide attempt and suicide in users of hormonal contraception. METHOD: The authors assessed associations between hormonal contraceptive use and suicide attempt and suicide in a nationwide prospective cohort study of all women in Denmark who had no psychiatric diagnoses, antidepressant use, or hormonal contraceptive use before age 15 and who turned 15 during the study period, which extended from 1996 through 2013. Nationwide registers provided individually updated information about use of hormonal contraception, suicide attempt, suicide, and potential confounding variables. Psychiatric diagnoses or antidepressant use during the study period were considered potential mediators between hormonal contraceptive use and risk of suicide attempt. Adjusted hazard ratios for suicide attempt and suicide were estimated for users of hormonal contraception as compared with those who never used hormonal contraception. RESULTS: Among nearly half a million women followed on average for 8.3 years (3.9 million person-years) with a mean age of 21 years, 6,999 first suicide attempts and 71 suicides were identified. Compared with women who never used hormonal contraceptives, the relative risk among current and recent users was 1.97 (95% CI=1.85-2.10) for suicide attempt and 3.08 (95% CI=1.34-7.08) for suicide. Risk estimates for suicide attempt were 1.91 (95% CI=1.79-2.03) for oral combined products, 2.29 (95% CI=1.77-2.95) for oral progestin-only products, 2.58 (95% CI=2.06-3.22) for vaginal ring, and 3.28 (95% CI=2.08-5.16) for patch. The association between hormonal contraceptive use and a first suicide attempt peaked after 2 months of use. CONCLUSIONS: Use of hormonal contraception was positively associated with subsequent suicide attempt and suicide. Adolescent women experienced the highest relative risk.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Skovlund CW, Mørch LS, Kessing LV, et al. Association of Hormonal Contraception With Suicide Attempts and Suicides. Am J Psychiatry. 2017. PMID: 29145752. doi:10.1176/appi.ajp.2017.17060616

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。